Extubation Failure and Major Adverse Events Secondary to Extubation Failure Following Neonatal Cardiac Surgery.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 18 8 2020
medline: 7 1 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

To describe the prevalence and consequences of major adverse events secondary to extubation failure after neonatal cardiac surgery. A single-center cohort study. A medical-surgical, 30-bed PICU in Victoria, Australia. One thousand one hundred eighty-eight neonates less than or equal to 28 days old who underwent cardiac surgery from January 2007 to December 2018. None. Extubation failure was defined as unplanned reintubation within 72 hours after a planned extubation. Major adverse event was defined as one or more of cardiac arrest, emergency chest reopening, extracorporeal membrane oxygenation, or death within 72 hours after extubation. One hundred fifteen of 1,188 (9.7%) neonates had extubation failure. Hospital mortality was 17.4% and 2.0% in neonates with and without extubation failure. Major adverse event occurred in 12 of 115 reintubated neonates (10.4%). major adverse event included cardiac arrest (n = 10), chest reopening (n = 8), extracorporeal membrane oxygenation (n = 5), and death (n = 0). Cardiovascular compromise accounted for major adverse event in eight: ventricular dysfunction (n = 3), pulmonary overcirculation (n = 2), coronary ischemia (n = 2), cardiac tamponade (n = 1). In a multivariable logistic regression, factors associated with major adverse event were high complexity in cardiac surgery (odds ratio 5.9; 95% CI: 1.1-32.2) and airway anomaly (odds ratio 6.0; 95% CI: 1.1-32.6). Hospital morality was 25% and 17% in reintubated neonates with and without major adverse event. Around 10% of reintubated neonates suffered major adverse event within 72 hours of extubation. Neonates suffering major adverse event had high mortality. Major adverse event should be monitored and reported in future studies of extubation failure. Along with tracking of extubation failure rates, major adverse event secondary to extubation failure may also serve as a key performance indicator for ICUs and registries.

Identifiants

pubmed: 32804741
doi: 10.1097/PCC.0000000000002470
pii: 00130478-202012000-00035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1119-e1125

Commentaires et corrections

Type : CommentIn

Références

Gaies M, Tabbutt S, Schwartz SM, et al. Clinical epidemiology of extubation failure in the pediatric cardiac ICU: A report from the pediatric cardiac critical care consortium. Pediatr Crit Care Med. 2015; 16:837–845
Miura S, Hamamoto N, Osaki M, et al. Extubation failure in neonates after cardiac surgery: prevalence, etiology, and risk factors. Ann Thorac Surg. 2017; 103:1293–1298
Scodellaro T, McKenzie JM, d’Udekem Y, et al. Extubation failure is associated with increased mortality following first stage single ventricle reconstruction operation. Pediatr Crit Care Med. 2017; 18:1136–1144
Mastropietro CW, Cashen K, Grimaldi LM, et al. Extubation failure after neonatal cardiac surgery: A multicenter analysis. J Pediatr. 2017; 182:190–196.e4
Laudato N, Gupta P, Walters HL III, et al. Risk factors for extubation failure following neonatal cardiac surgery. Pediatr Crit Care Med. 2015; 16:859–867
Gupta P, McDonald R, Gossett JM, et al. A single-center experience of extubation failure in infants undergoing the Norwood operation. Ann Thorac Surg. 2012; 94:1262–1268
Gupta P, Rettiganti M, Gossett JM, et al. Risk factors for mechanical ventilation and reintubation after pediatric heart surgery. J Thorac Cardiovasc Surg. 2016; 151:451–458.e3
Benneyworth BD, Mastropietro CW, Graham EM, et al. Variation in extubation failure rates after neonatal congenital heart surgery across Pediatric Cardiac Critical Care Consortium hospitals. J Thorac Cardiovasc Surg. 2017; 153:1519–1526
Gupta P, Jacobs JP, Pasquali SK, et al. Epidemiology and outcomes after in-hospital cardiac arrest after pediatric cardiac surgery. Ann Thorac Surg. 2014; 98:2138–2143; discussion 2144
Erek E, Aydin S, Suzan D, et al. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest in children after cardiac surgery. Anatol J Cardiol. 2017; 17:328–333
Gupta P, Rettiganti M, Jeffries HE, et al. Risk factors and outcomes of in-hospital cardiac arrest following pediatric heart operations of varying complexity. Resuscitation. 2016; 105:1–7
Dagan M, Butt W, d’Udekem Y, et al. Timing of in-hospital cardiac arrest after pediatric cardiac surgery: An important metric for quality improvement and prognostication? J Thorac Cardiovasc Surg. 2019; 157:e401–e406
Jenkins KJ, Gauvreau K, Newburger JW, et al. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002; 123:110–118
Jacobs JP, Jacobs ML, Lacour-Gayet FG, et al. Stratification of complexity improves the utility and accuracy of outcomes analysis in a Multi-Institutional Congenital Heart Surgery Database: Application of the Risk Adjustment in Congenital Heart Surgery (RACHS-1) and Aristotle Systems in the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database. Pediatr Cardiol. 2009; 30:1117–1130
Rooney SR, Donohue JE, Bush LB, et al. Extubation failure rates after pediatric cardiac surgery vary across hospitals. Pediatr Crit Care Med. 2019; 20:450–456
Gaies MG, Clarke NS, Donohue JE, et al. Personnel and unit factors impacting outcome after cardiac arrest in a dedicated pediatric cardiac intensive care unit. Pediatr Crit Care Med. 2012; 13:583–588
Gupta P, McDonald R, Goyal S, et al. Extubation failure in infants with shunt-dependent pulmonary blood flow and univentricular physiology. Cardiol Young. 2014; 24:64–72
Hernández G, Vaquero C, González P, et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016; 315:1354–1361
Hernández G, Vaquero C, Colinas L, et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA. 2016; 316:1565–1574
Lenzi J, Pildava S. Tips for calculating and displaying risk-standardized hospital outcomes in Stata. Stata J Promot Commun Stat Stata. 2019; 19:477–496
Butt W. Extubation failure after cardiac surgery: Can it be used as a metric for quality improvement and/or comparison of patient outcomes. Pediatr Crit Care Med. 2019; 20:495–496
Franklin D, Babl FE, Schlapbach LJ, et al. A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med. 2018; 378:1121–1131
Manley BJ, Arnolda GRB, Wright IMR, et al.; HUNTER Trial Investigators. Nasal high-flow therapy for newborn infants in special care nurseries. N Engl J Med. 2019; 380:2031–2040
Dodgen AL, Dodgen AC, Swearingen CJ, et al. Characteristics and hemodynamic effects of extubation failure in children undergoing complete repair for tetralogy of Fallot. Pediatr Cardiol. 2013; 34:1455–1462

Auteurs

Shinya Miura (S)

Paediatric Intensive Care Unit, The Royal Children's Hospital, Parkville, VIC, Australia.

Peter V Jardim (PV)

Paediatric Intensive Care Unit, The Royal Children's Hospital, Parkville, VIC, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.

Warwick Butt (W)

Paediatric Intensive Care Unit, The Royal Children's Hospital, Parkville, VIC, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

Siva P Namachivayam (SP)

Paediatric Intensive Care Unit, The Royal Children's Hospital, Parkville, VIC, Australia.
Murdoch Children's Research Institute, Parkville, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH